Navigation Links
IDI-MRSA Test

ProductsIDI-MRSA Test
Company Cepheid
Item IDI-MRSA Test
Features 
  • Only FDA-cleared, rapid molecular test
  • Exclusively on the SmartCycler System
  • Highly sensitive test
  • Results in less than 2 hours
  • Detects from a single nasal swab specimen
  • Meets CDC guidelines for isolation precautions
  • Detection as low as 5 CFU per reaction
  • Eliminates false positives from methicillin-resistant CoNS (coagulase-negative staphylococci)
  • Available in 50-test and 200-test kits
  • Significantly reduces hands-on time
Description IDI-MRSA is the first diagnostic test cleared by the FDA and by Health Canada for the direct detection of nasal colonization by methicillin resistant Staphylococcus aureus (MRSA). Based on the real-time PCR technology, IDI-MRSA test results are available in about one hour after the collection of a nasal swab, compared to other methods that require two to five days. By detecting a single genetic sequence specific of MRSA, the IDI-MRSA assay provides a full response in a single step.

With its unique features, IDI-MRSA provides a key tool for the control and prevention of MRSA infections.

Info Cepheid
Customer Service: (408) 541-4191
Web site: http://www.cepheid.com/

Related medicine products :

1. 300XL Xenon Light Source
2. Xenon XL Light Source
3. Xenon Light Source
4. Xenon Light Source 175W With Turret
5. Xenon Surgical Headlight System
6. View Mex-2 Portable Xenon Headlight
7. View Mex-3 Portable Xenon Headlight
8. AL1 180W Xenon Light Source
9. 8430W 300 Watt Xenon Light Source
10. 175 watt Xenon Light Source
11. LS 7500 Xenon Light Source
... following open renal or bladder surgeries. ... enhanced drainage and promote catheter retention. ... enhanced patient comfort and provides a ... sterile in peel-open packages. Intended for ...
... The Reflotron Plus Chemistry Analyzer is an ... quantitative determination of clinical chemistry parameters using Reflotron ... reflectance photometry and ensures rapid and reliable results ... on a clear LC display and the profile ...
... ASR contains primers, a FAM-labeled probe and an ... a 115 bp region of the 5' UTR. ... FAM, Alexa 532 and Texas Red reporter dyes ... Specific Reagent* (ASR) program is comprised of a ...
... The ClearChart Digital Acuity System is an ... an all-in-one design that eliminates the need ... ,Featuring a 15-inch LCD flat-panel screen, the ... refraction environment with the flexibility to mount ...
Medicine Products:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: